We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02592941
Brief Title: Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

First Submitted : October 29, 2015
First Submitted that Met QC Criteria : October 29, 2015
First Posted : October 30, 2015 (Estimate)

Last Update Submitted : August 15, 2017
Last Update Submitted that Met QC Criteria : August 15, 2017
Last Update Posted : August 18, 2017